Cited by 1,947Receptor Mechanisms and SignalingIon channel regulation and functionNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 3 of the 7 references it cites were found in a registry or an index, and 4 are not checked yet.

Guide to Receptors and Channels (GRAC), 5th edition

Open access

Alexander, SPH, Mathie, A, Peters, JA·2011·British Journal of Pharmacology

DOI 10.1111/j.1476-5381.2011.01649_1.xPMC PMC3315626

Open this paper in CoChat — free account Open PDF

Abstract

The Fifth Edition of the 'Guide to Receptors and Channels' is a compilation of the major pharmacological targets divided into seven sections: G protein-coupled receptors, ligand-gated ion channels, ion channels, catalytic receptors, nuclear receptors, transporters and enzymes. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside suggestions for further reading. Available alongside this publication is a portal at http://www.GuideToPharmacology.org which is produced in close association with NC-IUPHAR and allows free online access to the information presented in the Fifth Edition.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2011.01649_1.x

Cites

3 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects
Kanai, Y., & Hediger, M. A. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1146-4 · Cited by 450
The thermo‐TRP ion channel family: properties and therapeutic implications
Vay, L., Gu, C., & McNaughton, P. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01601.x · Cited by 313
Guide to Receptors and Channels (GRAC), 4th edition
Alexander, S. P. H., & Peters, J. A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00499.x · Cited by 249
Self-citation
The oligomeric state sets GABAB receptor signalling efficacy
Comps‐Agrar, L., Kniazeff, J., Nørskov-Lauritsen, L., Maurel, D., Gassmann, M., Gregor, N., Prézeau, L., Bettler, B., Durroux, T., Trinquet, E., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.143 · Cited by 103
Design and synthesis of the CB1 selective cannabinoid antagonist AM281: A potential human SPECT ligand
Lan, R., Lu, Q., Fan, P., Gatley, J. S., Volkow, N. D., Fernando, S. R., Pertwee, R. G., & Makriyannis, A. (1999) · AAPS PharmSci · doi:10.1208/ps010204 · Cited by 98
X. International Union of Pharmacology recommendations for nomenclature of new receptor subtypes.
Vanhoutte, P. M., Humphrey, P. P. A., & Spedding, M. (1996) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06936-4 · Cited by 78
The VPAC 2 agonist peptide histidine isoleucine (PHI) up‐regulates glutamate transport in the corpus callosum of a rat model of amyotrophic lateral sclerosis (hSOD1 G93A ) by inhibiting caspase‐3 mediated inactivation of GLT‐1a
Goursaud, S., Focant, M. C., Berger, J. V., Nizet, Y., Maloteaux, J., & Hermans, E. (2011) · The FASEB Journal · doi:10.1096/fj.11-182337 · Cited by 14

Show all 2 references

Sorted by citations

Items 101–200 of 1,000

The transient receptor potential channel antagonist SKF96365 is a potent blocker of low‐voltage‐activated T‐type calcium channels
Singh, A., Hildebrand, M. E., Garcı́a, E., & Snutch, T. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00786.x · Cited by 171
TRPV4 and the Regulation of Vascular Tone
Filosa, J. A., Yao, X., & Rath, G. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318279ba42 · Cited by 168
The Concise Guide to PHARMACOLOGY 2013/14: Overview
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., McGrath, J. C., Catterall, W. A., Spedding, M., Peters, J. A., Harmar, A. J., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12444 · Cited by 168
Self-citation
Advantages of an antagonist: bicuculline and other GABA antagonists
Johnston, G. A. R. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12127 · Cited by 185
Endocannabinoids and traumatic brain injury
Shohami, E., Cohen‐Yeshurun, A., Magid, L., Algali, M., & Mechoulam, R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01343.x · Cited by 167
Cannabidiol inhibits angiogenesis by multiple mechanisms
Solinas, M., Massi, P., Cantelmo, A. R., Cattaneo, M. G., Cammarota, R., Bartolini, D., Cinquina, V., Valenti, M., Vicentini, L. M., Noonan, D. M., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02050.x · Cited by 167
The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone
Samer, C. F., Daali, Y., Wagner, M., Gérard Hopfgartner, D., Eap, C. B., Rebsamen, M. C., Rossier, M., Hochstrasser, D. F., Dayer, P., & Desmeules, J. A. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00673.x · Cited by 166
Compounds from Sichuan and Melegueta peppers activate, covalently and non‐covalently, TRPA1 and TRPV1 channels
Riera, C. E., Menozzi-Smarrito, C., Affolter, M., Michlig, S., Munari, C., Robert, F., Vogel, H., Simon, S. A., & le Coutre, J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00307.x · Cited by 166
Benzodiazepine dependence and its treatment with low dose flumazenil
Hood, S. D., Norman, A., Hince, D. A., Melichar, J. K., & Hulse, G. K. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12023 · Cited by 165
Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re‐feeding
Izzo, A. A., Piscitelli, F., Capasso, R., Aviello, G., Romano, B., Borrelli, F., Petrosino, S., & Marzo, V. D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00183.x · Cited by 164
Regional enhancement of cannabinoid CB1 receptor desensitization in female adolescent rats following repeated Δ9‐tetrahydrocannabinol exposure
Burston, J. J., Wiley, J. L., Craig, A. A., Selley, D. E., & Sim‐Selley, L. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00870.x · Cited by 164
In vitroandin vivocharacterization of PF‐04418948, a novel, potent and selective prostaglandin EP2receptor antagonist
af Forselles, K., Root, J. A., Clarke, T. L., Davey, D. A., Aughton, K., Dack, K. N., & Pullen, N. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01495.x · Cited by 164
Vitamin D inhibits growth of human airway smooth muscle cells through growth factor‐induced phosphorylation of retinoblastoma protein and checkpoint kinase 1
Damera, G., Fogle, H., Lim, P. N., Goncharova, E. A., Zhao, H., Banerjee, A., Tliba, O., Krymskaya, V., & Panettieri, R. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00428.x · Cited by 163
Pre‐clinical properties of the α4β2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence
Rollema, H., Shrikhande, A., Ward, K., Tingley III, F., Coe, J., O'Neill, B., Tseng, E., Wang, E., Mather, R., Hurst, R., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00682.x · Cited by 162
Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors
Ferrada, C., Moreno, E., Casadó, V., Bongers, G., Cortés, A., Mallol, J., Canela, E. I., Leurs, R., Ferré, S., Lluı́s, C., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00152.x · Cited by 162
Endothelium‐dependent contractions in SHR: a tale of prostanoid TP and IP receptors
Félétou, M., Verbeuren, T. J., & Vanhoutte, P. M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00060.x · Cited by 162
Adenosine signaling contributes to ethanol-induced fatty liver in mice
Peng, Z., Borea, P. A., Wilder, T., Yee, H. T., Chiriboga, L. A., Blackburn, M. R., Azzena, G., Resta, G., & Cronstein, B. N. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37409 · Cited by 162
Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls
Buczynski, M. W., & Parsons, L. H. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00787.x · Cited by 171
On the relationship between block of the cardiac Na+channel and drug-induced prolongation of the QRS complex
Harmer, A., Valentin, J., & Pollard, C. E. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01415.x · Cited by 158
CB 1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model
Mukhopadhyay, P., Pan, H., Rajesh, M., Bátkai, S., Patel, V., Harvey-White, J. D., Mukhopadhyay, B., Haskó, G., Gao, B., Mackie, K., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00769.x · Cited by 156
Functional relevance of neurotransmitter receptor heteromers in the central nervous system
Ferré, S., Ciruela, F., Woods, A. S., Lluı́s, C., & Franco, R. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.07.001 · Cited by 157
Prostanoid receptor antagonists: development strategies and therapeutic applications
Jones, R., Giembycz, M. A., & Woodward, D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00317.x · Cited by 160
Clozapine, but not haloperidol, enhances glial d ‐serine and L‐glutamate release in rat frontal cortex and primary cultured astrocytes
Tanahashi, S., Yamamura, S., Nakagawa, M., Motomura, E., & Okada, M. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01638.x · Cited by 155
Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt‐dependent mechanisms
Xia, L., Wang, X., Hu, X., Guo, X., Shang, Y., Chen, H. J., Zeng, C., Zhang, F. R., & Chen, J. Z. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.272 · Cited by 154
TRPV4 Agonists and Antagonists
Vincent, F., & Duncton, M. A. J. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611796904861 · Cited by 154
Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity
Liaudet, L., Calderari, B., & Pacher, P. (2014) · Heart Failure Reviews · doi:10.1007/s10741-014-9418-y · Cited by 150
Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6
Alhouayek, M., Masquelier, J., Cani, P. D., Lambert, D. M., & Muccioli, G. G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314017110 · Cited by 152
cAMP signal transduction in the heart: understanding spatial control for the development of novel therapeutic strategies
Zaccolo, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00185.x · Cited by 159
The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function
Meyer, M. R., Prossnitz, E. R., & Barton, M. (2011) · Vascular Pharmacology · doi:10.1016/j.vph.2011.06.003 · Cited by 153
Pannexins, distant relatives of the connexin family with specific cellular functions?
D’hondt, C., Ponsaerts, R., SMEDT, H. D., Bultynck, G., & Himpens, B. (2009) · BioEssays · doi:10.1002/bies.200800236 · Cited by 153
Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor‐dependent osteoblastic functions in UMR 106 cells
Mok, S.-K., Chen, W., Lai, W., Leung, P., Wang, X., Yao, X., & Wong, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00593.x · Cited by 152
New concepts in pharmacological efficacy at 7 TM receptors: IUPHAR R eview 2
Kenakin, T. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02223.x · Cited by 153
The IUPHAR/BPS guide to PHARMACOLOGY in 2022: curating pharmacology for COVID-19, malaria and antibacterials
Harding, S. D., Armstrong, J. F., Faccenda, E., Southan, C., Alexander, S. P. H., Davenport, A. P., Pawson, A. J., Spedding, M., Davies, J. A., & NC-IUPHAR (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab1010 · Cited by 149
Self-citation
Preventive and therapeutic anti‐inflammatory properties of the sesquiterpene α‐humulene in experimental airways allergic inflammation
Rogério, A. D. P., de Andrade, E. L., Leite, D. F. P., Figueiredo, C. P., & Calixto, J. Β. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00177.x · Cited by 149
Ligand‐directed signalling within the opioid receptor family
Pradhan, A. A. A., Smith, M. L., Kieffer, B. L., & Evans, C. J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02075.x · Cited by 149
17(R)‐resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception
Bang, S., Yoo, S., Yang, T., Cho, H., & Hwang, S. W. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01568.x · Cited by 148
Suppressing inflammation by inhibiting the NF‐κB pathway contributes to the neuroprotective effect of angiotensin‐(1‐7) in rats with permanent cerebral ischaemia
Jiang, T., Gao, L., Guo, J., Lu, J., Wang, Y., & Zhang, Y. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02105.x · Cited by 150
Does GPER Really Function as a G Protein-Coupled Estrogen Receptor in vivo?
Luo, J., & Liu, D. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00148 · Cited by 147
Cannabinoid‐1 receptor activation induces reactive oxygen species‐dependent and ‐independent mitogen‐activated protein kinase activation and cell death in human coronary artery endothelial cells
Rajesh, M., Mukhopadhyay, P., Haskó, G., Liaudet, L., Mackie, K., & Pacher, P. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00712.x · Cited by 145
Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as anin vivoinhibitor of BCRP
Kusuhara, H., Furuie, H., Inano, A., Sunagawa, A., Yamada, S., Wu, C., Fukizawa, S., Morimoto, N., Ieiri, I., Morishita, M., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01887.x · Cited by 153
The homeostatic role of neuropeptide Yin immune function and its impact on mood and behaviour
Farzi, A., Reichmann, F., & Holzer, P. (2015) · Acta Physiologica · doi:10.1111/apha.12445 · Cited by 145
Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor‐expressing cells: implications for its therapeutic action
Marques-da-Silva, C., Chaves, M. M., Castro, N. G., Coutinho‐Silva, R., & Guimaraes, M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01254.x · Cited by 145
Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3
Subramaniam, A., Shanmugam, M. K., Ong, T. H., Li, F., Perumal, E., Chen, L., Vali, S., Abbasi, T., Kapoor, S., Ahn, K. S., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12302 · Cited by 146
Natural and synthetic modulators of SK (Kca2) potassium channels inhibit magnesium‐dependent activity of the kinase‐coupled cation channel TRPM7
Chubanov, V., y Schnitzler, M. M., Meißner, M., Schäfer, S., Abstiens, K., Hofmann, T., & Gudermann, T. W. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01855.x · Cited by 147
Activation and desensitization of TRPV1 channels in sensory neurons by the PPARα agonist palmitoylethanolamide
Ambrosino, P., Soldovieri, M. V., Russo, C., & Taglialatela, M. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12029 · Cited by 144
The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so
Kell, D. B., Dobson, P. D., Bilsland, E., & Oliver, S. G. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.11.008 · Cited by 144
The choroid plexus: a missing link in our understanding of brain development and function
Saunders, N. R., Dzięgielewska, K. M., Fame, R. M., Lehtinen, M. K., & Liddelow, S. A. (2022) · Physiological Reviews · doi:10.1152/physrev.00060.2021 · Cited by 145
A role for L‐α‐lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells
Ford, L., Roelofs, A. J., Anavi‐Goffer, S., Mowat, L., Simpson, D. G., Irving, A. J., Rogers, M. J., Rajnicek, A. M., & Ross, R. A. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00743.x · Cited by 146
Potential anxiolytic‐ and antidepressant‐like effects of salvinorin A, the main active ingredient of Salvia divinorum , in rodents
Braida, D., Capurro, V., Zani, A., Rubino, T., Viganò, D., Parolaro, D., & Sala, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00230.x · Cited by 141
Squalene targets pro- and anti-inflammatory mediators and pathways to modulate over-activation of neutrophils, monocytes and macrophages
Cárdeno, A., Aparicio‐Soto, M., la Paz, S. M., Bermúdez, B., Muriana, F. J. G., & Alarcón‐de‐la‐Lastra, C. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.03.009 · Cited by 148
The apelin receptor inhibits the angiotensin II type 1 receptor via allosteric trans‐inhibition
Siddiquee, K., Hampton, J., McAnally, D., May, L. T., & Smith, L. H. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02192.x · Cited by 141
Stimulation of angiotensin AT2receptors by the non‐peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats
Bosnyak, S., Welungoda, I., Hallberg, A., Alterman, M., Widdop, R. E., & Jones, E. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00575.x · Cited by 140
Dendritic ion channel trafficking and plasticity
Shah, M. M., Hammond, R., & Hoffman, D. A. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.03.002 · Cited by 142
Central and peripheral sites of action for CB 2 receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats
Hsieh, G. C., Pai, M., Chandran, P., Hooker, B. A., Zhu, C. Z., Salyers, A. K., Wensink, E. J., Zhan, C., Carroll, W. A., Dart, M. J., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01046.x · Cited by 139
Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS‐1E beta‐cells
Øzbay, L. A., Smidt, K., Mortensen, D. M., Carstens, J., Jørgensen, K. A., & Rungby, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01018.x · Cited by 139
The Calcium-Sensing Receptor Beyond Extracellular Calcium Homeostasis: Conception, Development, Adult Physiology, and Disease
Riccardi, D., & Kemp, P. J. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020911-153318 · Cited by 137
Autonomic Neurotransmission: 60 Years Since Sir Henry Dale
Burnstock, G. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.052808.102215 · Cited by 137
Chronic blockade of cannabinoid CB2receptors induces anxiolytic‐like actions associated with alterations in GABAAreceptors
García‐Gutiérrez, M. S., García‐Bueno, B., Zoppi, S., Leza, J. C., & Manzanares, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01625.x · Cited by 137
Efficacy and ligand bias at the μ‐opioid receptor
Kelly, E. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12222 · Cited by 136
TheGinkgo bilobaextract EGb 761®and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex
Yoshitake, T., Yoshitake, S., & Kehr, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00580.x · Cited by 139
Cannabinoids mediate opposing effects on inflammation‐induced intestinal permeability
Alhamoruni, A., Wright, K. L., Larvin, M., & O’Sullivan, S. E. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01589.x · Cited by 138
The plant cannabinoid Δ 9 ‐tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice
Bolognini, D., Costa, B., Maione, S., Comelli, F., Marini, P., Marzo, V. D., Parolaro, D., Ross, R. A., Gauson, L. A., Cascio, M. G., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00756.x · Cited by 135
Inhibition of inducible NO synthase, cyclooxygenase‐2 and interleukin‐1β by torilin is mediated by mitogen‐activated protein kinases in microglial BV2 cells
Choi, Y., Lee, M., Lim, S., Sung, S., & Kim, Y. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00022.x · Cited by 134
Nonsynaptic Communication Through ATP Release from Volume-Activated Anion Channels in Axons
Fields, R. D., & Ni, Y. (2010) · Science Signaling · doi:10.1126/scisignal.2001128 · Cited by 136
Vascular Aging in Women: is Estrogen the Fountain of Youth?
Novella, S., Dantas, A. P., Segarra, G., Medina, P., & Hermenegildo, C. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00165 · Cited by 148
Human Skin Microcirculation
Cracowski, J., & Roustit, M. (2020) · Comprehensive physiology · doi:10.1002/cphy.c190008 · Cited by 201
Inhibition of COX‐2 expression by endocannabinoid 2‐arachidonoylglycerol is mediated via PPAR‐γ
Du, H., Chen, X., Zhang, J., & Chen, C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01444.x · Cited by 136
Transient receptor potential ankyrin receptor 1 is a novel target for pro‐tussive agents
Andrè, E., Gatti, R., Trevisani, M., Preti, D., Pg, B., Patacchini, R., & Geppetti, P. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00438.x · Cited by 133
The 5‐lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages
Rossi, A., Pergola, C., Koeberle, A., Hoffmann, M., Dehm, F., Bramanti, P., Cuzzocrea, S., Werz, O., & Sautebin, L. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00930.x · Cited by 133
D6 and the atypical chemokine receptor family: Novel regulators of immune and inflammatory processes
Graham, G. J. (2009) · European Journal of Immunology · doi:10.1002/eji.200838858 · Cited by 135
AF‐353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist
Gever, J. R., Soto, R., Henningsen, R. A., Martin, R. S., Hackos, D. H., Panicker, S., Rubas, W., Oglesby, I. B., Dillon, M. P., Milla, M. E., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00796.x · Cited by 132
Molecular properties of muscarinic acetylcholine receptors
Haga, T. (2013) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.89.226 · Cited by 130
Inhibition of microsomal prostaglandin E2synthase‐1 as a molecular basis for the anti‐inflammatory actions of boswellic acids from frankincense
Siemoneit, U., Koeberle, A., Rossi, A., Dehm, F., Verhoff, M., Reckel, S., Maier, T., Jauch, J., Northoff, H., Bernhard, F., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01020.x · Cited by 129
Zebrafish: a model for the study of addiction genetics
Klee, E. W., Schneider, H., Clark, K. J., Cousin, M. A., Ebbert, J. O., Hooten, W. M., Karpyak, V. M., Warner, D. O., & Ekker, S. C. (2011) · Human Genetics · doi:10.1007/s00439-011-1128-0 · Cited by 131
Signal transduction and functional selectivity of F15599, a preferential post‐synaptic 5‐HT1Areceptor agonist
Newman‐Tancredi, A., Martel, J.-C., Assié, M. B., Buritova, J., Lauressergues, E., Cosi, C., Heusler, P., Slot, L. A. B., Colpaert, F. C., Vacher, B., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00001.x · Cited by 128
Role of GPER in estrogen-dependent nitric oxide formation and vasodilation
Fredette, N. C., Meyer, M. R., & Prossnitz, E. R. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.05.006 · Cited by 126
Reversal of acid‐induced and inflammatory pain by the selective ASIC3 inhibitor, APETx2
Karczewski, J., Spencer, R. H., Garsky, V. M., Liang, A., Leitl, M. D., Cato, M. J., Cook, S. P., Kane, S. A., & Urban, M. O. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00918.x · Cited by 126
Dynamic monitoring of beating periodicity of stem cell‐derived cardiomyocytes as a predictive tool for preclinical safety assessment
Abassi, Y. A., Xi, B., Li, N., Ouyang, W., Seiler, A., Watzele, M., Kettenhofen, R. F., Bohlen, H., Ehlich, A., Kolossov, E., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01623.x · Cited by 125
Neuroprotection by donepezil against glutamate excitotoxicity involves stimulation of α7 nicotinic receptors and internalization of NMDA receptors
Shen, H., Kihara, T., Hongo, H., Wu, X., Kem, W. R., Shimohama, S., AKAIKE, A., Niidome, T., & Sugimoto, H. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00894.x · Cited by 123
Pathology‐specific effects of the I Kur / I to / I K,ACh blocker AVE0118 on ion channels in human chronic atrial fibrillation
Christ, T., Wettwer, E., Voigt, N., Hála, O., Radicke, S., Matschke, K., Varró, A., Dobrev, D., & Ravens, U. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.209 · Cited by 121
Imidazoline Receptor System: The Past, the Present, and the Future
Bousquet, P., Hudson, A. L., Garcı́a-Sevilla, J. A., & Li, J. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.016311 · Cited by 124
The effects of Δ 9 ‐tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis
Jamontt, J., Molleman, A., Pertwee, R. G., & Parsons, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00791.x · Cited by 129
SZ‐685C, a marine anthraquinone, is a potent inducer of apoptosis with anticancer activity by suppression of the Akt/FOXO pathway
Xie, G., Zhu, X., Li, Q., Gu, M., He, Z., Wu, J., Li, J., Lin, Y., Li, M., She, Z., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00577.x · Cited by 122
Modulation of gastrointestinal function by MuDelta, a mixed µ opioid receptor agonist/ µ opioid receptor antagonist
Wade, P., Palmer, J., McKenney, S. L., Kenigs, V. A., Chevalier, K. M., Moore, B. W., Mabus, J., Saunders, P. R., Wallace, N., Schneider, C. R., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02068.x · Cited by 122
Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2)
Burger, H., Zoumaro-Djayoon, A. D., Boersma, A., Helleman, J., Berns, E., Mathijssen, R. H. J., Loos, W., & Wiemer, E. A. C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00569.x · Cited by 122
Impairment of both nitric oxide‐mediated and EDHF‐type relaxation in small mesenteric arteries from rats with streptozotocin‐induced diabetes
Leo, C., Hart, J. L., & Woodman, O. L. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01023.x · Cited by 122
Endothelin Receptor Signaling: New Insight Into Its Regulatory Mechanisms
Horinouchi, T., Terada, K., Higashi, T., & Miwa, S. (2013) · Journal of Pharmacological Sciences · doi:10.1254/jphs.13r02cr · Cited by 122
Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases
Schäcke, H., Zollner, T., Döcke, W., Rehwinkel, H., Jaroch, S., Skuballa, W., Neuhaus, R., May, E., Zügel, U., & Asadullah, K. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00238.x · Cited by 121
Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110)
Suen, J. Y., Barry, G. D., Lohman, R., Halili, M. A., Cotterell, A. J., Le, G. T., & Fairlie, D. P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01610.x · Cited by 123
Activation of the spinal sigma‐1 receptor enhances NMDA‐induced pain via PKC‐ and PKA‐dependent phosphorylation of the NR1 subunit in mice
Kim, H., Roh, D., Yoon, S., Seo, H., Kwon, Y., Han, H. J., Kim, K.-W., Beitz, A. J., & Lee, J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.159 · Cited by 121
Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain
Guindon, J., Guijarro, A. I., Piomelli, D., & Hohmann, A. G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01192.x · Cited by 120
Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways
Gómez, O., Sanchez‐Rodriguez, A., Le, M., Sanchez‐Caro, C., Molina‐Holgado, F., & Molina‐Holgado, E. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01414.x · Cited by 120
Cannabidiol, extracted fromCannabis sativa, selectively inhibits inflammatory hypermotility in mice
Capasso, R., Borrelli, F., Aviello, G., Romano, B., Scalisi, C., Capasso, F., & Izzo, A. A. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.177 · Cited by 122
Inhibition of T‐type Ca2+channels by endostatin attenuates human glioblastoma cell proliferation and migration
Zhang, Y., Zhang, J., Jiang, D., Zhang, D., Qian, Z., Liu, C., & Tao, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01852.x · Cited by 119
Cannabidiol ameliorates cognitive and motor impairments in bile‐duct ligated mice via 5‐HT1A receptor activation
Magen, I., Avraham, Y., Ackerman, Z., Vorobiev, L., Mechoulam, R., & Berry, E. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00589.x · Cited by 125
Endothelial actions of atrial and B‐type natriuretic peptides
Kühn, M. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01827.x · Cited by 121
Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases
Siller-Matula, J. M., Krumphuber, J., & Jilma, B. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00555.x · Cited by 118
Polymorphisms of ADORA2A modulate psychomotor vigilance and the effects of caffeine on neurobehavioural performance and sleep EEG after sleep deprivation
Bodenmann, S., Hohoff, C., Freitag, C. M., Deckert, J., Rétey, J., Bachmann, V., & Landolt, H. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01689.x · Cited by 125
The emerging chondrocyte channelome
Barrett‐Jolley, R. (2010) · Frontiers in Physiology · doi:10.3389/fphys.2010.00135 · Cited by 118
Cannabinoid CB1receptor‐interacting proteins: novel targets for central nervous system drug discovery?
Smith, T. H., Sim‐Selley, L. J., & Selley, D. E. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00777.x · Cited by 119

Authors: Alexander, S., Mathie, A., & Peters, J.
Affiliations: University of Nottingham (GB)
Medway School of Pharmacy (GB)
University of Dundee (GB)
ORCID: Mathie, A
Venue: British Journal of Pharmacology
Publisher: Wiley
Published: 2011-11
Volume: 164
Issue: s1
Pages: S1-324
ISSN: 0007-1188 (ISSN-L)
1476-5381
DOI: 10.1111/j.1476-5381.2011.01649_1.x
PMC: PMC3315626
OpenAlex: W2069380892
Cited by: 1,947
References: 2
Citations by year: 2026: 4 · 2025: 13 · 2024: 12 · 2023: 14 · 2022: 23 · 2021: 19 · 2020: 20 · 2019: 35 · 2018: 27 · 2017: 36 · 2016: 47 · 2015: 59 · 2014: 71 · 2013: 191 · 2012: 279
FWCI: 109.61
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: British Journal of Pharmacology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Discovery Research Portal (University of Dundee) (submittedVersion)
Kent Academic Repository (University of Kent) (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: therapeutic target, G protein-coupled receptors, ligand-gated ion channels, ion channels, nuclear receptors, transporters, enzymes, receptor nomenclature, pharmacological tools
MeSH terms: Animals, Humans, Ion Channels, Receptors, Cell Surface, Receptors, Cytoplasmic and Nuclear

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Guide to Receptors and Channels (GRAC), 5th edition

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks